Intravitreal aflibercept for myopic choroidal neovascularization-Reference-Cited by-同舟云学术

Intravitreal aflibercept for myopic choroidal neovascularization

Published:2016-06-11 Issue:12 Volume:254 Page:2327-2332
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Pece Alfredo,Milani Paolo

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-016-3396-9.pdf

Reference33 articles.

1. Wong TY, Ferreira A, Hughes R et al (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157:9–25.e12

2. Soubrane G (2008) Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment. Surv Ophthalmol 53:121–138

3. Pece A, Serini P, Avanza P, Brancato R (1990) Degenerative myopia: recurrence of subretinal neovessels after laser photocoagulation. J Fr Ophthalmol 13:24–28

4. Verteporfin in Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomised clinical trial-VIP report no. 1. Ophthalmology 108:841–852

5. Pece A, Isola V, Vadalà M, Matranga D (2006) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study. Retina 26:746–751

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization;Experimental and Therapeutic Medicine;2023-05-09

2. Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development;Computational and Mathematical Methods in Medicine;2022-05-09

3. Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown;Journal of Clinical Medicine;2022-04-08

4. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization;International Ophthalmology;2022-03-31

5. Result of intravitreal aflibercept injection for myopic choroidal neovascularization;BMC Ophthalmology;2021-09-22